Cargando…
Comprehensive Analysis and Experimental Validation of a Novel Estrogen/Progesterone-Related Prognostic Signature for Endometrial Cancer
Estrogen and progesterone are the major determinants of the occurrence and development of endometrial cancer (EC), which is one of the most common gynecological cancers worldwide. Our purpose was to develop a novel estrogen/progesterone-related gene signature to better predict the prognosis of EC an...
Autores principales: | Yu, Jing, Yao, Hong-Wen, Liu, Ting-Ting, Wang, Di, Shi, Jian-Hong, Yuan, Guang-Wen, Ma, Sai, Wu, Ling-Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225250/ https://www.ncbi.nlm.nih.gov/pubmed/35743699 http://dx.doi.org/10.3390/jpm12060914 |
Ejemplares similares
-
Distribution of estrogen and progesterone receptors isoforms in endometrial cancer
por: Kreizman-Shefer, Hila, et al.
Publicado: (2014) -
Pan-Cancer Prognostic Role and Targeting Potential of the Estrogen-Progesterone Axis
por: Shen, Yu-ting, et al.
Publicado: (2021) -
Microarray Analysis on Gene Regulation by Estrogen, Progesterone and Tamoxifen in Human Endometrial Stromal Cells
por: Ren, Chun-E, et al.
Publicado: (2015) -
The relationship of cerb B 2 expression with estrogen receptor and progesterone receptor and prognostic parameters in endometrial carcinomas
por: Gul, Aylin Ege, et al.
Publicado: (2010) -
Estrogen Receptor, Progesterone Receptor, and HER2 Receptor Markers in Endometrial Cancer
por: Wang, Caifeng, et al.
Publicado: (2020)